Optimizing Xenium In Situ data utility by quality assessment and best practice analysis workflows


Journal article


Sergio Marco Salas, Paulo Czarnewski, L. B. Kuemmerle, Saga Helgadottir, Christoffer Matsson-Langseth, Sebastian Tismeyer, Christophe Avenel, Habib Rehman, Katarina Tiklova, Axel Andersson, Maria Chatzinikolaou, F. Theis, Malte D. Luecken, C. Wählby, Naveed Ishaque, M. Nilsson
bioRxiv, 2023

Semantic Scholar DOI
Cite

Cite

APA   Click to copy
Salas, S. M., Czarnewski, P., Kuemmerle, L. B., Helgadottir, S., Matsson-Langseth, C., Tismeyer, S., … Nilsson, M. (2023). Optimizing Xenium In Situ data utility by quality assessment and best practice analysis workflows. BioRxiv.


Chicago/Turabian   Click to copy
Salas, Sergio Marco, Paulo Czarnewski, L. B. Kuemmerle, Saga Helgadottir, Christoffer Matsson-Langseth, Sebastian Tismeyer, Christophe Avenel, et al. “Optimizing Xenium In Situ Data Utility by Quality Assessment and Best Practice Analysis Workflows.” bioRxiv (2023).


MLA   Click to copy
Salas, Sergio Marco, et al. “Optimizing Xenium In Situ Data Utility by Quality Assessment and Best Practice Analysis Workflows.” BioRxiv, 2023.


BibTeX   Click to copy

@article{sergio2023a,
  title = {Optimizing Xenium In Situ data utility by quality assessment and best practice analysis workflows},
  year = {2023},
  journal = {bioRxiv},
  author = {Salas, Sergio Marco and Czarnewski, Paulo and Kuemmerle, L. B. and Helgadottir, Saga and Matsson-Langseth, Christoffer and Tismeyer, Sebastian and Avenel, Christophe and Rehman, Habib and Tiklova, Katarina and Andersson, Axel and Chatzinikolaou, Maria and Theis, F. and Luecken, Malte D. and Wählby, C. and Ishaque, Naveed and Nilsson, M.}
}

Abstract

The Xenium In Situ platform is a new spatial transcriptomics product commercialized by 10X Genomics capable of mapping hundreds of transcripts in situ at a subcellular resolution. Given the multitude of commercially available spatial transcriptomics technologies, recommendations in choice of platform and analysis guidelines are increasingly important. Herein, we explore eight preview Xenium datasets of the mouse brain and two of human breast cancer by comparing scalability, resolution, data quality, capacities and limitations with eight other spatially resolved transcriptomics technologies. In addition, we benchmarked the performance of multiple open source computational tools when applied to Xenium datasets in tasks including cell segmentation, segmentation-free analysis, selection of spatially variable genes and domain identification, among others. This study serves as the first independent analysis of the performance of Xenium, and provides best-practices and recommendations for analysis of such datasets.


Share



Follow this website


You need to create an Owlstown account to follow this website.


Sign up

Already an Owlstown member?

Log in